Skip to main content
OpenTrials
Completed

NCT Number: NCT05110235

PEG Application Experiences to Geriatric Patients

Percutaneous endoscopic gastrostomy (PEG) is currently the chosen minimally invasive, endoscopic procedure for medium- and long-term enteral feeding in cases who need palliative care. The presented study evaluated geriatric (> 65-year-old) PEG-applied patients at our institution.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Okan University Hospital

Istanbul, 34734, Turkey (Türkiye)

About this study

Palliative care is a treatment method that focuses on the patient and patient's family, aims to minimize the complaints caused by chronic diseases that cannot be treated, and increases life quality. The National Institute for Health and Care Excellence defines palliative care as; the active, holistic care of patients with an advanced progressive illness. Management of pain and other symptoms and providing psychological, social, and spiritual support is paramount. Anorexia, weight loss, and sarcopenia are highly visible and distressing reminders of the life-limiting disease's influence on patients who require palliative care. Given this multifaceted and significant role, it is not unexpected that nutritional treatment method choices can be challenging.

Percutaneous endoscopic gastrostomy (PEG) is a minimally-invasive endoscopic procedure that creates a passage from the patient's stomach to the abdominal wall via a feeding tube and provides a means of feeding if oral intake is not adequate. This safe and effective minimally-invasive option has been utilized in medical practice for over 40 years. PEG has advantages such as being minimally invasive, causing a low rate of complications and morbidity, and providing a long-lasting and safe feeding route. It is currently the chosen procedure for medium- and long-term enteral feeding in cases who need palliative care.

The application of PEG in geriatric-palliative care has not been well discussed. With the development of endoscopic procedures and PEG devices, this minimally invasive method can be applied more safely, even in challenging cases. This study discuss the indications of PEG in the field of palliative care of geriatric patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PEG applied >65-year-old patients at our institution between December 2017 and March 2021 -

Exclusion criteria

We excluded the patients who were not treated in our palliative care center

-

Treatment and study plan

Primary outcomes

  1. Hemoglobin (gr/dl)

    Time frame: 30 days

    30 th day hemoglobin levels after PEG application

  2. Albumin (gr/dl)

    Time frame: 30 days

    30 th day albumin levels after PEG application

Sponsors and collaborators

Lead sponsor

Okan University

Other

Registry information

Official study title

PERCUTANEOUS ENDOSCOPIC GASTROSTOMY APPLICATION EXPERIENCES TO GERIATRIC PATIENTS IN PALLIATIVE CARE UNIT

Important dates

Study start
2017
Primary completion
2021
Study completion
2021
First posted
Nov 5, 2021
Registry last updated
Nov 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.